APPLICATION
ANDA202928
TYPE
ANDA
ORIGINAL APPROVAL
2014-02-10
LATEST ACTION
2025-02-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
CLOPIDOGREL BISULFATEPrescription
CLOPIDOGREL BISULFATE EQ 75MG BASE · TABLET · ORAL
Approval history
2025-02-25Labeling · Supplement 32 · standardAP
2025-02-25Labeling · Supplement 29 · standardAP
2021-09-15Labeling · Supplement 26 · standardAP
2019-09-20Labeling · Supplement 20 · standardAP
2019-06-26Labeling · Supplement 15 · standardAP
2019-06-26Labeling · Supplement 11 · standardAP
2019-06-26Labeling · Supplement 8 · standardAP
2019-06-26Labeling · Supplement 14 · standardAP
2019-06-26Labeling · Supplement 9 · standardAP
2016-05-10Labeling · Supplement 5 · standardAP
2014-02-10UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.